Aditya Ambegaonkar, MD
Cardiovascular Disease (Cardiology) · La Mirada
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 25 years
- Saint Louis University School of Medicine, 2001
Offices
3 locations · Pih Health Physicians · 616 clinicians in this group
Hospitals listed: Pih Health Hospital-Whittier. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ambegaonkar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A81483 · Current
Licensed to practise in California · since 2002 · expires 2028-06-30 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Pih Health Hospital-WhittierWhittier, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of PIH Health, which runs 3 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.497, Oct 2024 – Sep 2025
See every measure and the patient survey for Pih Health Hospital-Whittier
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.497 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.83 (0 to 1.8) · 1,222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.08 (0.77 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 165.59 (122.43 to 208.75) · 99 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 64 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 323 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 360 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 553 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 4,869 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 6,090 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 6,261 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.56 (3.44 to 7.67) · 1,178 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.98 (0.31 to 3.64) · 255 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (1.77 to 4.79) · 1,113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.32 (5.89 to 20.76) · 256 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.43 to 9.49) · 249 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.11) · 236 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.12 (0 to 0.71) · 5,179 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 140 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.825 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.474 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.445 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.39 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 509 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 1,125 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.1 · 147 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27 · 401 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.4 · 400 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.3 · 1,019 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.3 to 7.4) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (10.4 to 18.1) · 71 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (10.1 to 16.6) · 1,770 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 397 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,178 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$165,232
Medicare paid this office $165,232 for 1,250 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 315 | $51,770 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $24,636 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 396 | $24,082 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $22,974 | $138 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 704 | $6,531 | $6 |
See all 17 services
| Return visit (30+ min) | 315 | $51,770 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $24,636 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 396 | $24,082 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $22,974 | $138 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 704 | $6,531 | $6 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 32 | $6,487 | $197 |
| New patient visit (45+ min) | 36 | $5,000 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $3,435 | $107 |
| Short return visit (20+ min) | 28 | $1,710 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 87 | $1,516 | $17 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,041 | $87 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 87 | $998 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 78 | $958 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $775 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 28 | $575 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 22 | $334 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $56 | $3 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 18 | More than 45% of doctors who do this |
Who their Medicare patients are
1,250 Original Medicare patients in 2024. Average age 76 · Under 65 13% · 85 and older 22% · Women 57% · Also on Medicaid 46% · Health risk score 2.71. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 54% · Chronic kidney disease 47% · Heart failure 44% · Coronary heart disease 43% · Atrial fibrillation 37% · Depression 30% · COPD 25% · Stroke 22% · Cancer 20% · Dementia 20%.
The office billed $676,646, Medicare allowed $220,215 and paid $165,232; for 3,167 services of 45 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,250 | 3,167 | 76 | 2.71 | $676,646 | $165,232 |
| 2023 | 1,430 | 3,520 | 75 | 2.52 | $721,362 | $179,568 |
| 2022 | 1,386 | 3,461 | 75 | 2.42 | $595,359 | $172,904 |
| 2021 | 1,235 | 3,338 | 75 | 2.59 | $560,859 | $167,437 |
| 2020 | 1,280 | 3,419 | 74 | 2.88 | $552,441 | $163,419 |
| 2019 | 1,553 | 4,031 | 75 | 2.80 | $673,426 | $185,601 |
| 2018 | 1,589 | 3,845 | 75 | 2.72 | $588,566 | $154,769 |
| 2017 | 1,556 | 3,697 | 76 | 2.64 | $530,478 | $145,005 |
| 2016 | 1,566 | 3,788 | 75 | 2.59 | $478,531 | $149,676 |
| 2015 | 1,478 | 3,350 | 75 | 2.67 | $442,823 | $139,174 |
| 2014 | 1,572 | 3,844 | 75 | 2.39 | $475,835 | $143,798 |
| 2013 | 1,660 | 3,981 | 75 | 2.40 | $516,846 | $149,978 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 22 services
| Return visit (30+ min) | 314 | $55,731 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 154 | $25,693 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 420 | $25,570 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 129 | $19,464 | $138 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 865 | $8,323 | $7 |
| New patient visit (45+ min) | 50 | $6,384 | $128 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 51 | $5,699 | $108 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,278 | $480 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $4,817 | $193 |
| Short return visit (20+ min) | 50 | $3,983 | $70 |
| New patient visit (30+ min) | 25 | $2,058 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 89 | $1,612 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 32 | $1,506 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,359 | $91 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 89 | $1,087 | $12 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,067 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 89 | $1,061 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $429 | $17 |
| Ultrasound of heart, follow-up | 12 | $340 | $21 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 20 | $315 | $16 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $91 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $76 | $3 |
2022: 20 services
| Return visit (30+ min) | 260 | $46,804 | $102 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $24,591 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $23,090 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $12,910 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $11,856 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 856 | $8,243 | $7 |
| New patient visit (45+ min) | 64 | $8,007 | $125 |
| Short return visit (20+ min) | 95 | $7,532 | $67 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $6,672 | $222 |
| New patient visit (30+ min) | 28 | $2,365 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,580 | $93 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 87 | $1,569 | $18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,300 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | $1,056 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 87 | $1,050 | $12 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,023 | $31 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 21 | $432 | $16 |
| Ultrasound of heart, follow-up | 11 | $367 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $294 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $96 | $3 |
2021: 21 services
| Return visit (30+ min) | 215 | $39,733 | $106 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 367 | $23,995 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 122 | $20,913 | $60 |
| Short return visit (20+ min) | 163 | $16,151 | $71 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 89 | $10,572 | $112 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,157 | $169 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 763 | $8,045 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $5,355 | $214 |
| New patient visit (45+ min) | 39 | $5,007 | $128 |
| New patient visit (30+ min) | 37 | $3,323 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 94 | $1,766 | $19 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 27 | $1,641 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 108 | $1,432 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,224 | $94 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 94 | $1,183 | $12 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $983 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $748 | $29 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $491 | $18 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $376 | $16 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $236 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 22 | $60 | $3 |
2020: 21 services
| Return visit (30+ min) | 223 | $31,028 | $85 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 374 | $25,897 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $24,409 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $12,416 | $177 |
| Telephone medical discussion with physician, 11-20 minutes | 125 | $10,053 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 846 | $9,258 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $7,849 | $121 |
| New patient visit (45+ min) | 55 | $6,981 | $127 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $6,149 | $220 |
| Short return visit (20+ min) | 79 | $4,685 | $50 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,942 | $97 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 91 | $1,758 | $19 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,685 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 85 | $1,306 | $15 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 19 | $1,241 | $31 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 91 | $1,176 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 21 | $489 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $374 | $16 |
| Ultrasound of heart, follow-up | 11 | $251 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $99 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $72 | $7 |
2019: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 161 | $30,258 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 432 | $29,892 | $64 |
| Return visit (30+ min) | 199 | $27,826 | $85 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 130 | $17,148 | $117 |
| Short return visit (20+ min) | 196 | $14,619 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,068 | $11,785 | $7 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,782 | $175 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,332 | $452 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $6,017 | $194 |
| New patient visit (45+ min) | 36 | $4,919 | $137 |
| New patient visit (30+ min) | 36 | $3,156 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 91 | $1,718 | $19 |
| Return visit (30+ min) | 19 | $1,363 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 87 | $1,326 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 91 | $1,179 | $13 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,145 | $95 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 15 | $980 | $29 |
| New patient visit (30+ min) | 13 | $852 | $66 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 24 | $533 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $337 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 30 | $89 | $3 |
2018: 19 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 411 | $25,773 | $61 |
| Short return visit (20+ min) | 249 | $21,689 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 131 | $21,547 | $62 |
| Return visit (30+ min) | 135 | $17,119 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 130 | $16,929 | $114 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,112 | $11,956 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,952 | $213 |
| New patient visit (30+ min) | 55 | $4,565 | $83 |
| New patient visit (45+ min) | 34 | $4,343 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,177 | $155 |
| New patient visit (30+ min) | 32 | $1,998 | $62 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 100 | $1,821 | $18 |
| Return visit (30+ min) | 18 | $1,337 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 88 | $1,291 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 100 | $1,257 | $12 |
| Follow-up observation care per day, typically 25 minutes | 14 | $936 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 27 | $622 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $205 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $52 | $3 |
2017: 20 services
| Short return visit (20+ min) | 277 | $28,874 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 149 | $23,578 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 408 | $23,010 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 150 | $19,781 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,086 | $11,712 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,159 | $191 |
| New patient visit (30+ min) | 52 | $4,628 | $89 |
| Return visit (30+ min) | 34 | $2,575 | $68 |
| Return visit (30+ min) | 34 | $2,339 | $67 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,682 | $93 |
| New patient visit (30+ min) | 24 | $1,559 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 63 | $1,162 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 60 | $867 | $14 |
| Programming of dual lead implantable defibrillator system | 13 | $862 | $36 |
| Follow-up observation care per day, typically 25 minutes | 14 | $827 | $59 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 63 | $786 | $12 |
| Programming of dual lead pacemaker system | 20 | $691 | $33 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $314 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 11 | $253 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $65 | $3 |
2016: 22 services
| Short return visit (20+ min) | 265 | $28,656 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 155 | $26,524 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 425 | $24,508 | $54 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 135 | $17,972 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,140 | $11,371 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $7,099 | $222 |
| New patient visit (30+ min) | 54 | $4,323 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,247 | $171 |
| Return visit (30+ min) | 33 | $2,394 | $67 |
| Return visit (30+ min) | 20 | $1,888 | $82 |
| New patient visit (45+ min) | 16 | $1,764 | $110 |
| New patient visit (30+ min) | 22 | $1,432 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 68 | $1,240 | $18 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,239 | $103 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $1,128 | $29 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 76 | $1,081 | $14 |
| Programming of dual lead implantable defibrillator system | 12 | $965 | $46 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 68 | $826 | $12 |
| Follow-up observation care per day, typically 25 minutes | 12 | $802 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 20 | $453 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $251 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $60 | $3 |
2015: 20 services
| Short return visit (20+ min) | 241 | $24,523 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $23,965 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 162 | $20,854 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 369 | $20,291 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,007 | $9,812 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $7,802 | $223 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,200 | $480 |
| New patient visit (30+ min) | 58 | $5,158 | $89 |
| Return visit (30+ min) | 34 | $2,831 | $79 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,634 | $96 |
| New patient visit (30+ min) | 19 | $1,226 | $65 |
| Programming of dual lead implantable defibrillator system | 12 | $1,201 | $67 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 17 | $1,032 | $28 |
| Short return visit (20+ min) | 19 | $896 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 62 | $890 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 47 | $851 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 47 | $564 | $12 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 17 | $387 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $312 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 23 | $70 | $3 |
2014: 21 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 477 | $26,920 | $53 |
| Short return visit (20+ min) | 248 | $26,205 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 175 | $21,178 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 173 | $20,966 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,113 | $11,308 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $6,028 | $232 |
| New patient visit (30+ min) | 44 | $3,869 | $88 |
| Return visit (30+ min) | 28 | $2,523 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,297 | $88 |
| New patient visit (30+ min) | 26 | $1,661 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 91 | $1,653 | $18 |
| New patient visit (45+ min) | 13 | $1,422 | $109 |
| Return visit (30+ min) | 16 | $1,252 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $1,166 | $28 |
| Short return visit (20+ min) | 22 | $1,159 | $43 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 89 | $1,088 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 56 | $802 | $14 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 12 | $725 | $60 |
| Ultrasound of heart blood flow, valves and chambers | 32 | $545 | $16 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 11 | $324 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 40 | $128 | $3 |
2013: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $26,121 | $58 |
| Short return visit (20+ min) | 223 | $24,829 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 453 | $24,772 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 172 | $20,085 | $111 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,209 | $11,551 | $7 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,760 | $228 |
| New patient visit (30+ min) | 39 | $3,292 | $84 |
| Ultrasound of heart with probe in esophagus, with report | 23 | $1,953 | $85 |
| New patient visit (30+ min) | 31 | $1,925 | $62 |
| Return visit (30+ min) | 22 | $1,768 | $80 |
| Return visit (30+ min) | 20 | $1,396 | $63 |
| Short return visit (20+ min) | 30 | $1,357 | $40 |
| Programming of dual lead implantable defibrillator system | 11 | $1,291 | $68 |
| New patient visit (45+ min) | 11 | $1,055 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 63 | $990 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 48 | $878 | $18 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $773 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 46 | $560 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 34 | $512 | $15 |
| Injection for imaging of aorta above heart valve with review by radiologist | 11 | $428 | $39 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $250 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $178 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $134 | $3 |
Medicaid work
$20,952 in 2024
Medicaid paid $20,952 for 1,739 billed services this clinician did in 2024, up to 134 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,506 | $11,948 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 194 | $7,333 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $880 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $792 |
| 2024 | 1,739 | 4 | 134 | $20,952 |
| 2023 | 2,002 | 3 | 230 | $28,240 |
| 2022 | 1,851 | 2 | 113 | $25,073 |
| 2021 | 1,425 | 2 | 192 | $18,408 |
| 2020 | 1,353 | 2 | 162 | $14,774 |
| 2019 | 1,437 | 2 | 155 | $17,941 |
| 2018 | 1,390 | 2 | 116 | $13,242 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,778 | $16,993 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 200 | $9,379 |
| Return visit (30+ min) | 24 | $1,868 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,655 | $15,596 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 196 | $9,478 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,312 | $12,763 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 113 | $5,645 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,290 | $12,210 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 63 | $2,563 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,323 | $12,436 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 114 | $5,505 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,290 | $9,285 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 100 | $3,957 |
Drugs they prescribed that Part D paid
$1,955,525
Pharmacies billed $1,955,525 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 8,123) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
6,305 generic and 1,818 brand-name prescriptions · $1,955,525 in drug cost · 167 antibiotic prescriptions to 88 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 1,098 | $1,300,438 | $1,184 |
| Xarelto | 306 | $364,228 | $1,190 |
| Entresto | 82 | $101,712 | $1,240 |
| Brilinta | 35 | $42,906 | $1,226 |
| Repatha Sureclick | 36 | $34,521 | $959 |
See all 44 drugs
| Eliquis | 1,098 | $1,300,438 | $1,184 |
| Xarelto | 306 | $364,228 | $1,190 |
| Entresto | 82 | $101,712 | $1,240 |
| Brilinta | 35 | $42,906 | $1,226 |
| Repatha Sureclick | 36 | $34,521 | $959 |
| Metoprolol | 807 | $12,672 | $16 |
| Metoprolol | 834 | $7,868 | $9 |
| Ranolazine Er | 49 | $7,055 | $144 |
| Losartan | 510 | $6,443 | $13 |
| Carvedilol | 592 | $6,403 | $11 |
| Atorvastatin | 363 | $4,752 | $13 |
| Diltiazem 24hr Er (Cd) | 111 | $4,248 | $38 |
| Furosemide | 569 | $4,178 | $7 |
| Clopidogrel | 247 | $3,677 | $15 |
| Isosorbide Mononitrate Er | 197 | $2,961 | $15 |
| Nitroglycerin | 276 | $2,910 | $11 |
| Digoxin | 83 | $2,907 | $35 |
| Potassium Chloride | 109 | $2,314 | $21 |
| Lisinopril | 272 | $2,189 | $8 |
| Amlodipine Besylate | 328 | $1,954 | $6 |
| Hydralazine | 101 | $1,842 | $18 |
| Valsartan | 41 | $1,441 | $35 |
| Diltiazem 24hr Er | 24 | $1,090 | $45 |
| Rosuvastatin | 51 | $1,007 | $20 |
| Sotalol | 36 | $957 | $27 |
| Benazepril | 56 | $927 | $17 |
| Diltiazem 12hr Er | 11 | $921 | $84 |
| Flecainide Acetate | 15 | $864 | $58 |
| Atenolol | 98 | $857 | $9 |
| Dilt-Xr | 18 | $787 | $44 |
| Losartan-Hydrochlorothiazide | 23 | $763 | $33 |
| Klor-Con 10 | 38 | $759 | $20 |
| Chlorthalidone | 22 | $744 | $34 |
| Nifedipine Er | 11 | $586 | $53 |
| Hydrochlorothiazide | 137 | $541 | $4 |
| Diltiazem 24hr Er (Xr) | 11 | $532 | $48 |
| Amiodarone | 28 | $487 | $17 |
| Diltiazem | 15 | $457 | $30 |
| Bisoprolol | 12 | $311 | $26 |
| Metolazone | 12 | $212 | $18 |
| Spironolactone | 12 | $171 | $14 |
| Amoxicillin | 149 | $122 | $1 |
| Azithromycin | 16 | $58 | $4 |
| Sildenafil Citrate | 14 | $23 | $2 |
Year by year
| 2024 | 8,123 | 1,306 | 0% (0) | 22% | $1,955,525 |
| 2023 | 8,719 | 1,257 | 0% (0) | 20% | $1,977,352 |
| 2022 | 7,764 | 1,197 | 0% (0) | 19% | $1,580,941 |
| 2021 | 6,889 | 1,056 | 0% (0) | 19% | $1,190,737 |
| 2020 | 5,597 | 1,016 | 0% (0) | 21% | $868,954 |
| 2019 | 5,316 | 992 | None | None | $663,971 |
| 2018 | 4,734 | 925 | None | None | $408,377 |
| 2017 | 3,831 | 805 | 0% (0) | 22% | $253,784 |
| 2016 | 3,531 | 704 | None | 21% | $152,833 |
| 2015 | 3,480 | 649 | None | 21% | $147,629 |
| 2014 | 3,454 | 621 | None | 18% | $127,255 |
| 2013 | 3,449 | 590 | 0% (0) | 16% | $109,939 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 47 drugs
| Eliquis | 1,093 | $1,279,125 | $1,170 |
| Xarelto | 295 | $347,496 | $1,178 |
| Entresto | 39 | $74,386 | $1,907 |
| Brilinta | 55 | $59,693 | $1,085 |
| Repatha Sureclick | 24 | $26,013 | $1,084 |
| Metoprolol | 801 | $20,951 | $26 |
| Losartan | 607 | $14,263 | $23 |
| Metoprolol | 904 | $11,706 | $13 |
| Carvedilol | 578 | $9,511 | $16 |
| Atorvastatin | 410 | $8,397 | $20 |
| Nitroglycerin | 403 | $7,382 | $18 |
| Ranolazine Er | 39 | $6,125 | $157 |
| Isosorbide Mononitrate Er | 205 | $5,922 | $29 |
| Diltiazem 24hr Er (Cd) | 78 | $5,437 | $70 |
| Furosemide | 638 | $5,210 | $8 |
| Digoxin | 123 | $4,970 | $40 |
| Clopidogrel | 228 | $4,768 | $21 |
| Amlodipine Besylate | 382 | $4,134 | $11 |
| Potassium Chloride | 129 | $3,997 | $31 |
| Lisinopril | 320 | $3,872 | $12 |
| Amiodarone | 61 | $3,859 | $63 |
| Rosuvastatin | 57 | $3,207 | $56 |
| Hydralazine | 104 | $2,964 | $28 |
| Valsartan | 41 | $2,882 | $70 |
| Atenolol | 122 | $1,834 | $15 |
| Benazepril | 63 | $1,792 | $28 |
| Sotalol | 28 | $1,406 | $50 |
| Dilt-Xr | 20 | $1,193 | $60 |
| Diltiazem 24hr Er | 17 | $1,146 | $67 |
| Losartan-Hydrochlorothiazide | 29 | $1,123 | $39 |
| Bisoprolol | 12 | $1,097 | $91 |
| Chlorthalidone | 21 | $922 | $44 |
| Flecainide Acetate | 15 | $904 | $60 |
| Labetalol | 18 | $866 | $48 |
| Tiadylt Er | 15 | $850 | $57 |
| Diltiazem 24hr Er (Xr) | 14 | $829 | $59 |
| Hydrochlorothiazide | 182 | $803 | $4 |
| Nifedipine Er | 17 | $784 | $46 |
| Klor-Con 10 | 26 | $774 | $30 |
| Diltiazem | 19 | $766 | $40 |
| Metolazone | 18 | $728 | $40 |
| Enalapril Maleate | 11 | $356 | $32 |
| Spironolactone | 20 | $315 | $16 |
| Simvastatin | 14 | $191 | $14 |
| Amoxicillin | 148 | $143 | $1 |
| Sildenafil Citrate | 21 | $126 | $6 |
| Azithromycin | 33 | $55 | $2 |
2022: 44 drugs
| Eliquis | 910 | $1,025,663 | $1,127 |
| Xarelto | 202 | $231,553 | $1,146 |
| Brilinta | 85 | $89,769 | $1,056 |
| Entresto | 27 | $39,647 | $1,468 |
| Metoprolol | 725 | $19,698 | $27 |
| Repatha Sureclick | 11 | $15,822 | $1,438 |
| Metoprolol | 862 | $9,966 | $12 |
| Losartan | 570 | $9,773 | $17 |
| Carvedilol | 504 | $7,977 | $16 |
| Nitroglycerin | 374 | $7,855 | $21 |
| Atorvastatin | 394 | $7,440 | $19 |
| Diltiazem 24hr Er (Cd) | 104 | $7,264 | $70 |
| Ranolazine Er | 31 | $6,776 | $219 |
| Digoxin | 127 | $5,121 | $40 |
| Furosemide | 569 | $4,676 | $8 |
| Isosorbide Mononitrate Er | 163 | $4,421 | $27 |
| Potassium Chloride | 122 | $3,983 | $33 |
| Clopidogrel | 199 | $3,934 | $20 |
| Lisinopril | 302 | $3,260 | $11 |
| Amlodipine Besylate | 305 | $3,076 | $10 |
| Rosuvastatin | 46 | $3,065 | $67 |
| Valsartan | 36 | $3,064 | $85 |
| Hydralazine | 69 | $2,419 | $35 |
| Atenolol | 120 | $1,938 | $16 |
| Sotalol | 35 | $1,702 | $49 |
| Labetalol | 15 | $1,208 | $81 |
| Benazepril | 54 | $988 | $18 |
| Amiodarone | 44 | $975 | $22 |
| Diltiazem 24hr Er | 15 | $925 | $62 |
| Hydrochlorothiazide | 162 | $861 | $5 |
| Diltiazem | 15 | $810 | $54 |
| Diltiazem 24hr Er (Xr) | 14 | $785 | $56 |
| Tiadylt Er | 11 | $769 | $70 |
| Flecainide Acetate | 12 | $741 | $62 |
| Losartan-Hydrochlorothiazide | 18 | $627 | $35 |
| Metolazone | 18 | $573 | $32 |
| Klor-Con 10 | 15 | $366 | $24 |
| Spironolactone | 25 | $288 | $12 |
| Triamterene-Hydrochlorothiazid | 15 | $268 | $18 |
| Simvastatin | 15 | $253 | $17 |
| Propranolol | 11 | $214 | $19 |
| Amoxicillin | 106 | $145 | $1 |
| Sildenafil Citrate | 13 | $111 | $9 |
| Azithromycin | 27 | $81 | $3 |
2021: 42 drugs
| Eliquis | 829 | $812,056 | $980 |
| Xarelto | 97 | $107,163 | $1,105 |
| Brilinta | 99 | $91,643 | $926 |
| Entresto | 25 | $22,405 | $896 |
| Metoprolol | 579 | $16,124 | $28 |
| Repatha Sureclick | 14 | $11,937 | $853 |
| Multaq | 12 | $8,947 | $746 |
| Metoprolol | 753 | $7,987 | $11 |
| Losartan | 448 | $7,720 | $17 |
| Ranolazine Er | 53 | $7,587 | $143 |
| Carvedilol | 511 | $7,395 | $14 |
| Atorvastatin | 371 | $6,656 | $18 |
| Diltiazem 24hr Er (Cd) | 85 | $6,603 | $78 |
| Nitroglycerin | 241 | $5,389 | $22 |
| Isosorbide Mononitrate Er | 177 | $4,832 | $27 |
| Digoxin | 133 | $4,771 | $36 |
| Furosemide | 534 | $4,142 | $8 |
| Potassium Chloride | 110 | $3,356 | $31 |
| Clopidogrel | 229 | $3,059 | $13 |
| Lisinopril | 294 | $3,018 | $10 |
| Amiodarone | 76 | $2,953 | $39 |
| Amlodipine Besylate | 269 | $2,431 | $9 |
| Hydralazine | 74 | $1,917 | $26 |
| Valsartan | 26 | $1,887 | $73 |
| Labetalol | 21 | $1,513 | $72 |
| Sotalol | 35 | $1,427 | $41 |
| Atenolol | 74 | $1,388 | $19 |
| Diltiazem 24hr Er | 23 | $1,310 | $57 |
| Rosuvastatin | 21 | $1,124 | $54 |
| Benazepril | 67 | $934 | $14 |
| Diltiazem | 14 | $844 | $60 |
| Metolazone | 35 | $836 | $24 |
| Nifedipine Er | 22 | $784 | $36 |
| Dilt-Xr | 11 | $766 | $70 |
| Hydrochlorothiazide | 113 | $590 | $5 |
| Klor-Con 10 | 20 | $400 | $20 |
| Triamterene-Hydrochlorothiazid | 19 | $292 | $15 |
| Spironolactone | 28 | $252 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $233 | $21 |
| Simvastatin | 24 | $172 | $7 |
| Amoxicillin | 74 | $99 | $1 |
| Azithromycin | 27 | $62 | $2 |
2020: 37 drugs
| Eliquis | 649 | $572,619 | $882 |
| Xarelto | 104 | $94,903 | $913 |
| Brilinta | 96 | $67,372 | $702 |
| Metoprolol | 402 | $12,039 | $30 |
| Atorvastatin | 289 | $6,724 | $23 |
| Carvedilol | 491 | $6,668 | $14 |
| Losartan | 342 | $6,085 | $18 |
| Metoprolol | 646 | $6,042 | $9 |
| Ranolazine Er | 28 | $4,865 | $174 |
| Isosorbide Mononitrate Er | 148 | $4,278 | $29 |
| Digoxin | 121 | $4,248 | $35 |
| Nitroglycerin | 170 | $3,608 | $21 |
| Clopidogrel | 204 | $3,239 | $16 |
| Lisinopril | 303 | $3,129 | $10 |
| Furosemide | 361 | $2,997 | $8 |
| Hydralazine | 78 | $2,727 | $35 |
| Potassium Chloride | 68 | $2,394 | $35 |
| Diltiazem 24hr Er (Cd) | 44 | $2,140 | $49 |
| Amlodipine Besylate | 239 | $2,001 | $8 |
| Amiodarone | 49 | $1,848 | $38 |
| Valsartan | 26 | $1,558 | $60 |
| Labetalol | 23 | $1,467 | $64 |
| Atenolol | 78 | $1,222 | $16 |
| Benazepril | 66 | $848 | $13 |
| Dilt-Xr | 13 | $747 | $57 |
| Sildenafil Citrate | 24 | $706 | $29 |
| Rosuvastatin | 12 | $656 | $55 |
| Sotalol | 17 | $638 | $38 |
| Metolazone | 24 | $573 | $24 |
| Cartia Xt | 11 | $528 | $48 |
| Hydrochlorothiazide | 87 | $483 | $6 |
| Klor-Con 10 | 17 | $421 | $25 |
| Clonidine | 15 | $337 | $22 |
| Spironolactone | 19 | $211 | $11 |
| Amoxicillin | 72 | $119 | $2 |
| Simvastatin | 14 | $71 | $5 |
| Azithromycin | 12 | $29 | $2 |
2019: 39 drugs
| Eliquis | 472 | $372,588 | $789 |
| Xarelto | 115 | $94,650 | $823 |
| Brilinta | 55 | $42,037 | $764 |
| Metoprolol | 336 | $16,935 | $50 |
| Multaq | 13 | $12,934 | $995 |
| Ranolazine Er | 27 | $8,839 | $327 |
| Carvedilol | 527 | $8,560 | $16 |
| Metoprolol | 613 | $7,646 | $12 |
| Atorvastatin | 235 | $6,833 | $29 |
| Losartan | 323 | $5,595 | $17 |
| Clopidogrel | 225 | $4,992 | $22 |
| Isosorbide Mononitrate Er | 174 | $4,585 | $26 |
| Nitroglycerin | 229 | $4,513 | $20 |
| Digoxin | 114 | $4,013 | $35 |
| Potassium Chloride | 105 | $3,842 | $37 |
| Lisinopril | 303 | $3,381 | $11 |
| Hydralazine | 81 | $3,366 | $42 |
| Diltiazem 24hr Er (Cd) | 24 | $3,093 | $129 |
| Furosemide | 358 | $2,938 | $8 |
| Valsartan | 24 | $2,846 | $119 |
| Amlodipine Besylate | 189 | $2,587 | $14 |
| Cartia Xt | 21 | $1,487 | $71 |
| Amiodarone | 41 | $1,463 | $36 |
| Dilt-Xr | 20 | $1,229 | $61 |
| Rosuvastatin | 11 | $1,152 | $105 |
| Atenolol | 71 | $1,030 | $15 |
| Digox | 23 | $1,010 | $44 |
| Hydrochlorothiazide | 121 | $723 | $6 |
| Metolazone | 26 | $715 | $27 |
| Klor-Con 10 | 26 | $707 | $27 |
| Diltiazem 24hr Er | 12 | $645 | $54 |
| Benazepril | 53 | $589 | $11 |
| Digitek | 17 | $564 | $33 |
| Sotalol | 13 | $524 | $40 |
| Pravastatin | 13 | $232 | $18 |
| Spironolactone | 11 | $130 | $12 |
| Warfarin | 11 | $96 | $9 |
| Simvastatin | 14 | $69 | $5 |
| Amoxicillin | 48 | $56 | $1 |
2018: 39 drugs
| Eliquis | 183 | $143,237 | $783 |
| Xarelto | 121 | $75,371 | $623 |
| Ranexa | 42 | $27,883 | $664 |
| Brilinta | 23 | $16,111 | $700 |
| Metoprolol | 287 | $15,713 | $55 |
| Multaq | 22 | $15,683 | $713 |
| Pradaxa | 16 | $9,531 | $596 |
| Carvedilol | 503 | $7,426 | $15 |
| Metoprolol | 577 | $7,314 | $13 |
| Diltiazem 24hr Er (Cd) | 57 | $7,193 | $126 |
| Clopidogrel | 232 | $5,652 | $24 |
| Isosorbide Mononitrate Er | 179 | $5,136 | $29 |
| Atorvastatin | 159 | $4,763 | $30 |
| Lisinopril | 304 | $4,197 | $14 |
| Digoxin | 102 | $4,148 | $41 |
| Losartan | 258 | $4,117 | $16 |
| Potassium Chloride | 102 | $3,579 | $35 |
| Nitroglycerin | 183 | $3,469 | $19 |
| Diovan | 11 | $3,384 | $308 |
| Amlodipine Besylate | 177 | $2,877 | $16 |
| Furosemide | 341 | $2,613 | $8 |
| Hydralazine | 67 | $2,415 | $36 |
| Amiodarone | 44 | $2,097 | $48 |
| Valsartan | 43 | $2,011 | $47 |
| Sotalol | 15 | $1,559 | $104 |
| Cartia Xt | 30 | $1,512 | $50 |
| Digox | 22 | $1,408 | $64 |
| Atenolol | 78 | $1,328 | $17 |
| Metolazone | 22 | $1,083 | $49 |
| Nitroglycerin Patch | 13 | $965 | $74 |
| Benazepril | 39 | $835 | $21 |
| Hydrochlorothiazide | 143 | $798 | $6 |
| Enalapril Maleate | 12 | $479 | $40 |
| Klor-Con 10 | 21 | $461 | $22 |
| Digitek | 12 | $379 | $32 |
| Spironolactone | 20 | $326 | $16 |
| Pravastatin | 16 | $286 | $18 |
| Warfarin | 20 | $166 | $8 |
| Amoxicillin | 29 | $50 | $2 |
2017: 39 drugs
| Eliquis | 94 | $67,401 | $717 |
| Xarelto | 81 | $55,387 | $684 |
| Ranexa | 44 | $20,156 | $458 |
| Brilinta | 15 | $12,731 | $849 |
| Multaq | 11 | $12,150 | $1,105 |
| Pradaxa | 23 | $10,868 | $473 |
| Metoprolol | 228 | $7,105 | $31 |
| Diltiazem 24hr Er | 70 | $5,372 | $77 |
| Digoxin | 119 | $4,876 | $41 |
| Carvedilol | 476 | $4,446 | $9 |
| Clopidogrel | 222 | $4,412 | $20 |
| Amiodarone | 72 | $4,371 | $61 |
| Metoprolol | 512 | $3,853 | $8 |
| Diltiazem 24hr Cd | 16 | $3,498 | $219 |
| Nitroglycerin | 151 | $3,398 | $23 |
| Potassium Chloride | 76 | $2,757 | $36 |
| Isosorbide Mononitrate Er | 153 | $2,736 | $18 |
| Lisinopril | 237 | $1,647 | $7 |
| Valsartan | 37 | $1,615 | $44 |
| Losartan | 129 | $1,526 | $12 |
| Furosemide | 268 | $1,348 | $5 |
| Atorvastatin | 77 | $1,159 | $15 |
| Hydralazine | 40 | $1,069 | $27 |
| Digox | 17 | $1,006 | $59 |
| Enoxaparin | 11 | $960 | $87 |
| Diltiazem | 14 | $911 | $65 |
| Nitroglycerin Patch | 12 | $781 | $65 |
| Metolazone | 21 | $725 | $35 |
| Amlodipine Besylate | 109 | $711 | $7 |
| Cartia Xt | 28 | $586 | $21 |
| Atenolol | 57 | $419 | $7 |
| Klor-Con 10 | 15 | $350 | $23 |
| Benazepril | 27 | $315 | $12 |
| Hydrochlorothiazide | 76 | $309 | $4 |
| Warfarin | 40 | $295 | $7 |
| Clonidine | 28 | $166 | $6 |
| Simvastatin | 25 | $154 | $6 |
| Spironolactone | 20 | $127 | $6 |
| Amoxicillin | 16 | $29 | $2 |
2016: 40 drugs
| Xarelto | 69 | $38,101 | $552 |
| Ranexa | 30 | $11,724 | $391 |
| Eliquis | 16 | $7,190 | $449 |
| Metoprolol | 183 | $6,776 | $37 |
| Diltiazem 24hr Er | 49 | $6,602 | $135 |
| Carvedilol | 435 | $5,644 | $13 |
| Digoxin | 112 | $5,625 | $50 |
| Pradaxa | 11 | $5,121 | $466 |
| Nitrostat | 104 | $4,992 | $48 |
| Metoprolol | 454 | $4,903 | $11 |
| Clopidogrel | 238 | $4,566 | $19 |
| Amiodarone | 104 | $4,013 | $39 |
| Isosorbide Mononitrate Er | 139 | $2,933 | $21 |
| Potassium Chloride | 87 | $2,579 | $30 |
| Digox | 34 | $2,534 | $75 |
| Valsartan | 36 | $2,496 | $69 |
| Lisinopril | 244 | $2,334 | $10 |
| Furosemide | 283 | $1,884 | $7 |
| Atorvastatin | 84 | $1,691 | $20 |
| Hydralazine | 40 | $1,597 | $40 |
| Isosorbide Dinitrate | 13 | $1,346 | $104 |
| Losartan | 92 | $1,273 | $14 |
| Enoxaparin | 11 | $1,145 | $104 |
| Diltiazem 24hr Cd | 19 | $897 | $47 |
| Nitroglycerin | 39 | $892 | $23 |
| Nitroglycerin Patch | 16 | $740 | $46 |
| Amlodipine Besylate | 70 | $663 | $9 |
| Simvastatin | 78 | $501 | $6 |
| Klor-Con 10 | 26 | $480 | $18 |
| Atenolol | 60 | $428 | $7 |
| Diltiazem | 13 | $384 | $30 |
| Lovastatin | 17 | $361 | $21 |
| Metolazone | 11 | $274 | $25 |
| Benazepril | 40 | $258 | $6 |
| Warfarin | 30 | $243 | $8 |
| Hydrochlorothiazide | 45 | $220 | $5 |
| Triamterene-Hydrochlorothiazid | 11 | $196 | $18 |
| Labetalol | 11 | $190 | $17 |
| Spironolactone | 12 | $95 | $8 |
| Amoxicillin | 12 | $21 | $2 |
2015: 35 drugs
| Xarelto | 81 | $39,116 | $483 |
| Ranexa | 32 | $11,716 | $366 |
| Carvedilol | 470 | $6,010 | $13 |
| Metoprolol | 505 | $5,418 | $11 |
| Clopidogrel | 235 | $5,091 | $22 |
| Valsartan | 33 | $5,086 | $154 |
| Metoprolol | 125 | $4,824 | $39 |
| Nitrostat | 166 | $3,938 | $24 |
| Digox | 53 | $3,819 | $72 |
| Digoxin | 80 | $3,637 | $45 |
| Potassium Chloride | 115 | $3,230 | $28 |
| Isosorbide Mononitrate Er | 125 | $3,050 | $24 |
| Crestor | 12 | $2,924 | $244 |
| Amiodarone | 89 | $2,702 | $30 |
| Lisinopril | 245 | $2,359 | $10 |
| Tekturna | 12 | $2,083 | $174 |
| Atorvastatin | 89 | $1,968 | $22 |
| Diltiazem 24hr Er | 24 | $1,962 | $82 |
| Furosemide | 282 | $1,877 | $7 |
| Diltiazem 24hr Cd | 22 | $1,517 | $69 |
| Losartan | 102 | $1,345 | $13 |
| Hydralazine | 28 | $1,332 | $48 |
| Metolazone | 24 | $1,103 | $46 |
| Taztia Xt | 16 | $1,037 | $65 |
| Nitroglycerin Patch | 18 | $926 | $51 |
| Cartia Xt | 20 | $805 | $40 |
| Simvastatin | 78 | $717 | $9 |
| Atenolol | 70 | $453 | $6 |
| Amlodipine Besylate | 57 | $389 | $7 |
| Lovastatin | 21 | $335 | $16 |
| Klor-Con 10 | 14 | $335 | $24 |
| Benazepril | 19 | $268 | $14 |
| Warfarin | 22 | $229 | $10 |
| Hydrochlorothiazide | 28 | $174 | $6 |
| Amoxicillin | 16 | $30 | $2 |
2014: 37 drugs
| Diovan | 45 | $18,165 | $404 |
| Xarelto | 32 | $14,186 | $443 |
| Ranexa | 24 | $8,815 | $367 |
| Carvedilol | 497 | $7,713 | $16 |
| Metoprolol | 549 | $7,072 | $13 |
| Clopidogrel | 233 | $6,123 | $26 |
| Valsartan | 20 | $6,082 | $304 |
| Amiodarone | 107 | $5,134 | $48 |
| Crestor | 15 | $4,056 | $270 |
| Isosorbide Mononitrate Er | 165 | $3,711 | $22 |
| Lisinopril | 266 | $3,323 | $12 |
| Digox | 46 | $3,076 | $67 |
| Potassium Chloride | 102 | $2,920 | $29 |
| Metoprolol | 65 | $2,780 | $43 |
| Digoxin | 62 | $2,562 | $41 |
| Nitrostat | 135 | $2,004 | $15 |
| Tekturna | 11 | $1,604 | $146 |
| Losartan | 92 | $1,556 | $17 |
| Furosemide | 254 | $1,545 | $6 |
| Hydralazine | 33 | $1,484 | $45 |
| Nitroglycerin Patch | 30 | $1,355 | $45 |
| Diltiazem 24hr Er | 24 | $1,288 | $54 |
| Atorvastatin | 64 | $1,272 | $20 |
| Felodipine Er | 20 | $1,035 | $52 |
| Diltiazem 24hr Cd | 11 | $1,030 | $94 |
| Simvastatin | 103 | $1,027 | $10 |
| Atenolol | 90 | $704 | $8 |
| Metolazone | 22 | $657 | $30 |
| Taztia Xt | 14 | $564 | $40 |
| Klor-Con 10 | 20 | $535 | $27 |
| Benazepril | 26 | $455 | $18 |
| Amlodipine Besylate | 54 | $455 | $8 |
| Klor-Con M10 | 13 | $447 | $34 |
| Lovastatin | 15 | $423 | $28 |
| Sotalol | 11 | $328 | $30 |
| Warfarin | 26 | $264 | $10 |
| Hydrochlorothiazide | 27 | $181 | $7 |
2013: 36 drugs
| Diovan | 47 | $13,568 | $289 |
| Clopidogrel | 301 | $8,509 | $28 |
| Carvedilol | 435 | $8,196 | $19 |
| Metoprolol | 575 | $7,996 | $14 |
| Crestor | 29 | $6,868 | $237 |
| Amiodarone | 85 | $5,566 | $65 |
| Isosorbide Mononitrate Er | 241 | $5,432 | $23 |
| Ranexa | 13 | $3,685 | $283 |
| Lisinopril | 234 | $3,000 | $13 |
| Potassium Chloride | 71 | $2,696 | $38 |
| Diltiazem 24hr Er | 26 | $2,268 | $87 |
| Nitrostat | 145 | $2,124 | $15 |
| Hydralazine | 40 | $2,012 | $50 |
| Felodipine Er | 32 | $2,006 | $63 |
| Atorvastatin | 62 | $1,935 | $31 |
| Metoprolol | 27 | $1,683 | $62 |
| Furosemide | 237 | $1,649 | $7 |
| Tekturna | 12 | $1,592 | $133 |
| Simvastatin | 125 | $1,476 | $12 |
| Nitroglycerin Patch | 32 | $1,358 | $42 |
| Cartia Xt | 22 | $1,335 | $61 |
| Losartan | 65 | $1,276 | $20 |
| Klor-Con 10 | 35 | $940 | $27 |
| Atenolol | 96 | $931 | $10 |
| Sotalol | 28 | $703 | $25 |
| Digox | 51 | $672 | $13 |
| Taztia Xt | 14 | $661 | $47 |
| Warfarin | 62 | $575 | $9 |
| Lovastatin | 24 | $553 | $23 |
| Klor-Con M10 | 13 | $480 | $37 |
| Benazepril | 22 | $426 | $19 |
| Metolazone | 21 | $366 | $17 |
| Amlodipine Besylate | 38 | $317 | $8 |
| Hydrochlorothiazide | 20 | $201 | $10 |
| Digoxin | 16 | $186 | $12 |
| Diltiazem | 11 | $128 | $12 |
Money from drug and device companies
$895 in 2025
| 2025 | 8 | 33 | None | $895 |
| 2024 | 12 | 40 | None | $1,105 |
| 2023 | 7 | 20 | None | $573 |
| 2022 | 6 | 21 | None | $460 |
| 2021 | 8 | 23 | None | $745 |
| 2020 | 6 | 14 | None | $405 |
| 2019 | 9 | 13 | None | $615 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Avvigo Guidance System | $450 | 15 payments
|
| Teleflex | Guideliner | $93 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $89 | 6 payments
|
| Bard Peripheral Vascular | Rotarexs 6 F X 135 Cm | $84 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $56 | 2 payments
|
| Biotronik | Orsiro Mission | $45 | 2 payments
|
See all 33 published payments
| Boston Scientific | Meals · 2025-12-31 | Avvigo Guidance System | $23 |
| Bard Peripheral Vascular | Meals · 2025-12-24 | Lutonix Drug Coated Balloon | $19 |
| Boston Scientific | Meals · 2025-12-16 | Avvigo Guidance System | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-12 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-12-04 | Avvigo Guidance System | $7 |
| Boston Scientific | Meals · 2025-11-24 | Avvigo Guidance System | $3 |
| Boston Scientific | Meals · 2025-11-18 | Avvigo Guidance System | $5 |
| Novartis Pharmaceuticals | Meals · 2025-11-06 | Leqvio | $28 |
| Boston Scientific | Meals · 2025-11-04 | Avvigo Guidance System | $27 |
| Boston Scientific | Meals · 2025-10-09 | Avvigo Guidance System | $19 |
| Boston Scientific | Meals · 2025-10-01 | Avvigo Guidance System | $5 |
| Bard Peripheral Vascular | Meals · 2025-09-19 | Rotarexs 6 F X 135 Cm | $33 |
| Novartis Pharmaceuticals | Meals · 2025-09-11 | Leqvio | $28 |
| Heartflow | Meals · 2025-09-08 | Ffrct | $41 |
| Boston Scientific | Meals · 2025-08-27 | Avvigo Guidance System | $25 |
| Boston Scientific | Meals · 2025-08-26 | Avvigo Guidance System | $6 |
| Boston Scientific | Meals · 2025-08-14 | Avvigo Guidance System | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-29 | Lifevest | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-15 | Lifevest | $6 |
| Boston Scientific | Meals · 2025-07-02 | Avvigo Guidance System | $101 |
| Boston Scientific | Meals · 2025-06-25 | Avvigo Guidance System | $21 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-06-18 | Lifevest | $19 |
| Teleflex | Meals · 2025-06-18 | Guideliner | $46 |
| Biotronik | Meals · 2025-06-12 | Orsiro Mission | $21 |
| Abiomed | Meals · 2025-06-06 | None | $37 |
| Biotronik | Meals · 2025-05-29 | Orsiro Mission | $24 |
| Bard Peripheral Vascular | Meals · 2025-05-09 | Rotarexs 6 F X 135 Cm | $15 |
| Boston Scientific | Meals · 2025-03-31 | Avvigo Guidance System | $26 |
| Teleflex | Meals · 2025-03-24 | Guideliner | $48 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-17 | Lifevest | $19 |
| Boston Scientific | Meals · 2025-03-14 | Avvigo Guidance System | $136 |
| Bard Peripheral Vascular | Meals · 2025-02-04 | Rotarexs 6 F X 135 Cm | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-20 | Lifevest | $20 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,105
| Boston Scientific | Avvigo Guidance System | $314 | 12 payments
|
| Abiomed | Impella | $219 | 6 payments
|
| Biotronik | Amvia Edge | $115 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $110 | 5 payments
|
| Abbott Laboratories | Xience Skypoint | $73 | 3 payments
|
| Kestra Medical Technology Services | Assure Wcd | $70 | 4 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $54 | 2 payments
|
| Teleflex | Turnpike | $46 | 1 payment
|
| Bard Peripheral Vascular | Rotarexs 6 F X 135 Cm | $37 | 2 payments
|
| Becton Dickinson and | Rotarexs 6 F X 135 Cm | $27 | 1 payment
|
| Chiesi USA | Kengreal | $20 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $19 | 1 payment
|
2023: $573
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $184 | 2 payments
|
| Abbott Laboratories | Xience Skypoint | $154 | 7 payments
|
| Boston Scientific | Avvigo Guidance System | $85 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $49 | 3 payments
|
| Teleflex | Guideliner | $41 | 2 payments
|
| Biotronik | Biomonitor | $34 | 1 payment
|
| Abiomed | Impella | $27 | 1 payment
|
2022: $460
| Cardiovascular Systems | Diamondback Coronary | $144 | 7 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $88 | 3 payments
|
| Chiesi USA | Kengreal | $87 | 4 payments
|
| Abbott Laboratories | Xience Sierra | $74 | 4 payments
|
| Teleflex | Chocolate | $42 | 2 payments
|
| Abiomed | Impella | $25 | 1 payment
|
2021: $745
| Cardiovascular Systems | Diamondback Coronary | $252 | 11 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent System | $197 | 2 payments
|
| Chiesi USA | Kengreal | $156 | 4 payments
|
| Philips Electronics North America | (9520) Igt Devices Und | $45 | 1 payment
|
| Medtronic | Micra | $29 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $28 | 1 payment
|
| Kiniksa Pharmaceuticals | None | $25 | 1 payment
|
| Pfizer | Vyndaqel | $13 | 1 payment
|
2020: $405
| Abbott Laboratories | Optis Coronary Imaging System | $158 | 3 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $98 | 4 payments
|
| Abiomed | Impella | $45 | 2 payments
|
| Medtronic Vascular | Corevalve Evolut | $44 | 2 payments
|
| Teleflex | Interventional Products | $36 | 2 payments
|
| Chiesi USA | Kengreal 50mg/10ml L | $25 | 1 payment
|
2019: $615
| Medtronic USA | Kyphon Balloon Kyphoplasty | $167 | 2 payments
|
| Abbott Laboratories | Xience Sierra Coronary Stent System | $163 | 1 payment
|
| Abiomed | Impella | $105 | 1 payment
|
| Medtronic Vascular | Micra | $44 | 2 payments
|
| Cardiovascular Systems | Coronary Orbital Atherectomy System | $44 | 2 payments
|
| Teleflex | Catheter - Turnpike | $32 | 2 payments
|
| Ge Healthcare | None | $23 | 1 payment
|
| Terumo Medical | Metacross | $23 | 1 payment
|
| Lantheus Medical Imaging | Definity | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922167667
- Licence
- CA A81483California A81483: Current · expires 2028-06-30
- Trained
- Saint Louis University School of Medicine, 2001 · 25 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 393 E Walnut St, 3rd Floor Phr Systems, Pasadena, CA, 91188
- NPI first listed
- 2006-12-08
- NPI last updated
- 2011-02-10
This is when the NPI record was last certified, not a medical board exam.